Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 14, Issue 10, Pages 2577-2590
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-07-16
DOI
10.1074/mcp.m115.052720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dinutuximab: First Global Approval
- (2015) Sohita Dhillon DRUGS
- Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies
- (2014) Katarzyna B. Koziara et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Immunization with a Mimotope of GD2 Ganglioside Induces CD8+ T Cells That Recognize Cell Adhesion Molecules on Tumor Cells
- (2014) A. Wierzbicki et al. JOURNAL OF IMMUNOLOGY
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
- (2013) Sander Pronk et al. BIOINFORMATICS
- Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma
- (2013) Michael Roth et al. CANCER
- Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells
- (2013) Irena Horwacik et al. CANCER LETTERS
- Crystal Structure of Anti-polysialic Acid Antibody Single Chain Fv Fragment Complexed with Octasialic Acid
- (2013) Masamichi Nagae et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Refinement of the application of the GROMOS 54A7 force field to β-peptides
- (2013) Zhixiong Lin et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Structural Evaluation of a Mimicry-Recognizing Paratope: Plasticity in Antigen-Antibody Interactions Manifests in Molecular Mimicry
- (2013) S. Tapryal et al. JOURNAL OF IMMUNOLOGY
- Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies
- (2013) Conor Fields et al. Nature Protocols
- In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors
- (2013) Mahiuddin Ahmed et al. PLoS One
- Carbohydrate–Aromatic Interactions
- (2012) Juan Luis Asensio et al. ACCOUNTS OF CHEMICAL RESEARCH
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Unique Ganglioside Recognition Strategies for Clostridial Neurotoxins
- (2011) Marc A. Benson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody
- (2009) Ariel Talavera et al. MOLECULAR IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started